HBK Investments’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

HBK Investments’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,300	Closed	-$230K	–	1213
2016 Q1	$230K	Sell	4,300 -24,135	-85%	-$1.78M	﹤0.01%	878
2015 Q4	$3.21M	Sell	28,435 -36,765	-56%	-$4.05M	0.03%	310
2015 Q3	$7.67M	Buy	65,200 +8,892	+16%	+$1.16M	0.08%	164
2015 Q2	$4.36M	Sell	56,308 -3,300	-6%	-$216K	0.04%	250
2015 Q1	$3.45M	Buy	+59,608	New	+$2.53M	0.03%	310

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

HBK Investments's ANAC Position: Q2 2016 in Review

HBK Investments sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 4,300 shares — an estimated $230K sold.

HBK Investments first reported a position in ANAC in Q1 2015 and held it in 5 quarters. The position peaked at $7.67M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

HBK Investments reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
HBK Investments sold 4,300 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $230K.
HBK Investments first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 5 quarters.
HBK Investments's ANACOR PHARMACEUTICALS INC COM position peaked at $7.67M in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on HBK Investments's 13F filing for Q2 2016, filed 15 Aug 2016.